Asal Qadan

Title: The Innovative Contributions of Asal Qadan

Introduction

Asal Qadan, based in Dresden, Germany, is a prominent inventor who has made significant advancements in the field of pharmaceuticals, specifically through her innovative work on multicomponent crystals. With a total of four patents to her name, Qadan has made remarkable strides in developing new treatments for pain conditions.

Latest Patents

Among her latest patents, Qadan's work includes the development of novel multicomponent crystals composed of ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid). This invention focuses on producing these crystals to treat pain conditions of unclear genesis, addressing pains caused by muscle tension, degenerative joint diseases, and inflammatory processes. The unique combination of active ingredients flupirtine and diclofenac can be achieved by dissolving them in a specific molar ratio within an inert organic solvent and subsequently crystallizing the compound.

Another significant patent involves the creation of multicomponent crystals made from flupirtine and an arylpropionic acid. This innovative approach again targets the treatment of various pain conditions while emphasizing the simultaneous effect on muscle tension and inflammatory-related pains.

Career Highlights

Asal Qadan has contributed her expertise to notable companies in the pharmaceutical industry, such as Teva GmbH and Teva Pharmaceuticals USA, Inc. Her career in these esteemed organizations has enabled her to collaborate on various projects that further the development of effective pain management therapies.

Collaborations

Throughout her career, Qadan has worked alongside distinguished professionals like Christoph Martin Hoock and Bernd Terhaag. These collaborations have fostered a dynamic exchange of ideas, bolstering her research efforts and enhancing the therapeutic applications of her inventions.

Conclusion

Asal Qadan stands as an inspiring figure in the realm of innovation and invention within pharmaceuticals. Her patents not only represent a commitment to advancing pain management solutions but also highlight the importance of collaborative efforts in achieving breakthroughs. With her ongoing contributions, Qadan continues to shape the future of treatment options for pain conditions.